Sterling
Merck & Co. logo
Merck & Co.
Moderna logo
Moderna

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Merck & Co. 16.607, Moderna 0.145.

Merck & Co. vs Moderna Net Worth and Market Cap

Merck & Co. (MRK) and Moderna (MRNA) are peers in Vaccines. Merck & Co. reported revenue of $16.6B as of Q2 2026, compared with $145M for Moderna. Merck & Co. leads on revenue.

Merck & Co.'s gross margin is 73.5% versus 35.9% for Moderna. Merck & Co.'s net margin is -8.0% versus -539.3% for Moderna.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Merck & Co. +5.1%, Moderna +2.1%.
  • Both made operating losses in their latest quarter: Merck & Co. at a -4.1% margin, Moderna at -562.1%.
  • Merck & Co.'s KPIs on Sterling include Merck Animal Health Livestock vs Companion Animal (Quarterly) and Merck Gardasil China Sales as Printed.
  • Moderna's KPIs on Sterling include Cash, Cash Equivalents and Investments (Quarterly) and Net Product Sales vs Deferred Revenue (Quarterly).

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., Moderna.
MetricMerck & Co.Moderna
Market Cap--
Revenue$16.61B$145.00M
Cost of Revenue$4.39B$93.00M
Gross Profit$12.21B$52.00M
Operating Income$-683.00M$-815.00M
Net Income$-1.33B$-782.00M
R&D Expense$9.74B$651.00M
Earnings Per Share-$0.54-$1.96
Gross Margin73.5%35.9%
Operating Margin-4.1%-562.1%
Net Profit Margin-8.0%-539.3%
Free Cash Flow$4.48B$-563.00M
Cumulative Free Cash Flow$249.70B$7.37B
Operating Cash Flow$5.37B$-526.00M
Cash & Equivalents$6.85B$1.72B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites